DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Funds / Medtech Convergence Fund, L.P.
Medtech Convergence Fund, L.P.
Amounts, each with its basis
- Vintage
- 2019basis: adv first reported
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- $94.0Mwhat may be sold, not what was raised; file 021-334664, sworn by the adviser or filed under this vehicle
- Form D sold
- $0as of the filing of Mar 12, 2019
- First sale
- unknown
- Reported GAV
- $31.9Mon the Form ADV filed Mar 28, 2024; the fund's assets, never its size or dry powder
- Owners (ADV)
- 2
- Reported on ADV
- Mar 29, 2019 to Mar 28, 2024
Fundraising evidence
Unknown
latest Form D 2019-03-12, older than 15 months (fr-1)
evidence dated Mar 12, 2019. A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Mature
vintage 4 to 7 years
age years: 7first sale: n/avintage year: $2,019adv gav as of: 2024-03-28vintage basis: adv_first_reportedform d sold usd: 0form d offering usd: $94.0Mform d latest filed at: 2019-03-12
The fund's own reporting through time
8 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 29, 2019 | Venture Capital Fund | $0 | 0 | 0% | no | ||
| May 29, 2019 | Venture Capital Fund | $0 | 0 | 0% | no | ||
| Mar 30, 2020 | Venture Capital Fund | $13.8M | 1 | 1% | yes | ||
| Mar 31, 2021 | Venture Capital Fund | $84.6M | 2 | 1% | yes | ||
| Apr 29, 2021 | Venture Capital Fund | $84.6M | 2 | 1% | yes | ||
| Mar 31, 2022 | Venture Capital Fund | $89.1M | 2 | 1% | yes | ||
| Mar 30, 2023 | Venture Capital Fund | $90.1M | 2 | 1% | yes | ||
| Mar 28, 2024 | Venture Capital Fund | $31.9M | 2 | 1% | yes |
Principals and agents
3 principals on Form D, 0 placement agents
- Aaron Sandoski Executive Officer
- Paul Laviolette Executive Officer
- Medtech Convergence GP LLC Executive Officer
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
2 events
- Mar 29, 2019Medtech Convergence Fund, L.P. first reported on Form ADV by SV Health Investors, LLC (Venture Capital Fund)Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 12, 2019Medtech Convergence Fund, L.P. filed Form D: no sales yet of $94,000,000, Venture Capital FundForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this vehicle
- Entity type: Limited Partnership Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Limited Partnership Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Form D fund type: Venture Capital Fund Fact SEC EDGAR Form D data sets (quarterly)
- Form D fund type: Venture Capital Fund Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pooled Investment Fund Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pooled Investment Fund Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Not Applicable Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Not Applicable Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $0 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $0 Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $94.0M Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $94.0M Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b, 3C, 3C.7 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b, 3C, 3C.7 Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 0 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 0 Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: pooled Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: pooled Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON, MA, 02108 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON, MA, 02108 Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2018 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2018 Mar 12, 2019 Fact SEC EDGAR Form D data sets (quarterly)